Bottle Label 600mg (43353 0872 70)
Gabapentin
Product Images NDC 43353-872
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 43353-872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Image (Gabapentin 05)
The text describes a chart showing the average pain scores during a medication trial. The trial involved a four-week period during which the medication dose was increased, followed by an eight-week period during which a fixed dose was given. The medications being studied were a placebo and gabapentin at a dose of 3600 mg/day. The chart displays the baseline score and pain scores at weeks 1-8.*
Image (Gabapentin 06)
Image (Gabapentin 07)
The text provides statistical data regarding the efficacy of treatments for controlled PHN (Postherpetic neuralgia) in two different studies. The figure shows the proportion of responders, i.e., patients with a pain score reduction of more than 50% at the endpoint of the study. The results indicate that in study 1, 34% of patients responded positively to treatment, while in study 2, the value was not available. The text also mentions the medication dosages used in these studies: GEP 3600, GBP 1800 and GBP 2400.*
Image (Gabapentin 08)
Equation 1 (Image 01)
This text appears to be a formula for calculating the creatinine clearance rate (CLCr) of a patient. The CLCr is important in assessing kidney function, as it measures the rate at which creatinine, a waste product that is filtered through the kidneys, is cleared from the body. The formula takes into account the patient's age, weight, and serum creatinine level, and adjusts the weight multiplier for female patients. This information could be useful for doctors or medical professionals in assessing kidney function in their patients.*
Structure (Struct)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
